Mechanisms of multidrug resistance and implications for therapy
- PMID: 3131279
- PMCID: PMC5917488
- DOI: 10.1111/j.1349-7006.1988.tb01588.x
Mechanisms of multidrug resistance and implications for therapy
Similar articles
-
[Multidrug resistance of malignant tumors].Orv Hetil. 1991 Oct 6;132(40):2187-92. Orv Hetil. 1991. PMID: 1682863 Review. Hungarian.
-
Multidrug resistance: mechanism and therapy.Jpn J Cancer Res. 1993 Dec;84(12):inside front cover. Jpn J Cancer Res. 1993. PMID: 8294209 Review. No abstract available.
-
The multidrug resistance phenotype.Br J Cancer. 1988 Dec;58(6):691-4. doi: 10.1038/bjc.1988.291. Br J Cancer. 1988. PMID: 3066393 Free PMC article. Review. No abstract available.
-
Multidrug resistance in the laboratory and clinic.Cancer Cells. 1989 Sep;1(1):33-6. Cancer Cells. 1989. PMID: 2701361 Review. No abstract available.
-
Multidrug resistance in cancer.Lancet. 1989 Nov 4;2(8671):1075-6. Lancet. 1989. PMID: 2572800 Review. No abstract available.
Cited by
-
Intravesical instillation of adriamycin in the presence or absence of verapamil for the treatment of superficial bladder cancer: preliminary report of a collaborative study.Cancer Chemother Pharmacol. 1992;30 Suppl:S50-4. doi: 10.1007/BF00686942. Cancer Chemother Pharmacol. 1992. PMID: 1394818 Clinical Trial.
-
Therapeutic efficacy of combination of antitumor agent with AHC-52 against multidrug-resistant cells in the intravenously inoculated P388 leukemia model.Cancer Chemother Pharmacol. 1992;30(5):335-40. doi: 10.1007/BF00689959. Cancer Chemother Pharmacol. 1992. PMID: 1505070
-
Mitomycin C cross-resistance induced by adriamycin in human ovarian cancer cells in vitro.Cancer Chemother Pharmacol. 1990;26(5):333-9. doi: 10.1007/BF02897288. Cancer Chemother Pharmacol. 1990. PMID: 1976451
-
Molecular mechanisms of drug resistance.Biochem J. 1990 Dec 1;272(2):281-95. doi: 10.1042/bj2720281. Biochem J. 1990. PMID: 1980062 Free PMC article. Review. No abstract available.
-
Enhancement of reversing effect of cyclosporin A on vincristine resistance by anti-P-glycoprotein monoclonal antibody MRK-16.Jpn J Cancer Res. 1993 May;84(5):489-92. doi: 10.1111/j.1349-7006.1993.tb00164.x. Jpn J Cancer Res. 1993. PMID: 8100562 Free PMC article.
References
-
- ) Biedler , J. L. and Peterson , R. H. F.Altered plasma membrane glyco‐conjugates of Chinese hamster cells with acquired resistance to actinomycin D, daunorubicin and vincristine . In “ Molecular Actions and Targets for Cancer Chemotherapeutic Agents ,” ed. Sartorelli A. C. , Lazo J. S. and Bertino J. R. , pp. 453 – 482 ( 1981. ). Academic Press; , New York .
-
- ) Ling , V.Genetic basis of drug resistance in mammalian cells . In “ Drug and Hormone Resistance in Neoplasia ,” Vol. 1 , ed. Bruchovsky N. and Goldie J. H. , pp. 1 – 19 ( 1983. ). CRC Press; , Miami .
-
- ) Chabner , B. A. , Clendeninn , N. J. and Curt , G. A.Symposium on cellular resistance to anticancer drugs . Cancer Treat. Rep. , 67 , 855 – 932 ( 1983. ). - PubMed
-
- ) Sugimoto , Y. and Tsuruo , T.Development of multidrug resistance in rodent cell lines . In “ Molecular and Cellular Biology of Multidrug Resistance in Tumor Cells ,” ed. Roninson I. B. ( 1988. ). Plenum Press; , New York , in press .
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources